Stratec (ETR:SBS) Shares Down 1.2% – Should You Sell?

Stratec SE (ETR:SBS) shares were down 1.2% during mid-day trading on Monday . The company traded as low as €32.75 ($34.11) and last traded at €33.30 ($34.69). Approximately 6,052 shares changed hands during mid-day trading, a decline of 3% from the average daily volume of 6,253 shares. The stock had previously closed at €33.70 ($35.10).

Stratec Trading Up 7.8 %

The company has a 50-day simple moving average of €30.36 and a 200 day simple moving average of €36.75. The company has a market capitalization of $420.74 million, a P/E ratio of 29.08, a P/E/G ratio of 10.43 and a beta of 0.16. The company has a debt-to-equity ratio of 65.99, a quick ratio of 1.65 and a current ratio of 2.47.

About Stratec

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.